Indaptus Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 05/15/2026 | 39.02 K | $71.01 K | 100.00% | 1.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 27.01 K | $49.15 K | 100.00% | 1.25% |
| MORGAN STANLEY | 05/15/2026 | 2.70 K | $4.91 K | 100.00% | 0.12% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.89 K | $3.44 K | -40.02% | 0.09% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 17 | $31 | 0.00% | 0.00% |
| CWM, LLC | 05/14/2026 | 2 | $4 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Indaptus Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 9 institutional investors and hedge funds held shares of Indaptus Therapeutics Inc. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 39,018
GEODE CAPITAL MANAGEMENT, LLC: 27,007
MORGAN STANLEY: 2,697
Tower Research Capital LLC (TRC): 1,890
SBI Securities Co., Ltd.: 17
CWM, LLC: 2
3.26% of Indaptus Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 70.69 K shares in the last 24 months. This purchase volume represents approximately $132.20 K in transactions.